Please select an option below to help us tailor your newsletter to best suit your content interests!
Pivotal, open-label, randomized study of radiosurgery with or without tumor treating fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC)
Pivotal, open-label, randomized study of radiosurgery with or without tumor treating fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC)
- Primary- Time to first cerebral progression; Secondary- Time to neurocognitive failure, radiologic response in the brain, time to second cerebral progression, OS, Intracranial PFS, time to distant progression in supratentorial region, rate of decline in cognitive function, QoL, Safety